XML 88 R36.htm IDEA: XBRL DOCUMENT v3.25.2
Share capital (Tables)
9 Months Ended
Jun. 30, 2025
Share capital  
Schedule of Authorized and Issued Capital Stock

 

 

 

 

 

Common Shares

 

 

 

 

 

Number

 

 

Amount

 

Balance, September 30, 2023

 

Note

 

 

 

33,832,784

 

 

 

115,041

 

Issuance of shares

 

(i)

 

 

10,024

 

 

 

30

 

Issuance of shares

 

(ii)

 

 

 

42,157

 

 

 

169

 

Transfer from contributed surplus

 

 

 

 

 

 

-

 

 

 

501

 

Exercise of options

 

 

 

 

 

 

252,700

 

 

 

667

 

Balance, September 30, 2024

 

 

 

 

 

 

34,137,665

 

 

$116,408

 

Issuance of shares

 

(iii) (iv)

 

 

 

5,951,250

 

 

 

11,582

 

Balance, December 31, 2024

 

 

 

 

 

 

40,088,915

 

 

 

127,990

 

Stock option exercised

 

 

 

 

 

 

18,000

 

 

 

72

 

Balance, March 31, 2025 and June 30, 2025

 

 

 

 

 

 

40,106,915

 

 

 

128,062

 

Schedule of Stock Options

 

 

Number outstanding

 

 

Weighted average exercise price

 

Outstanding, September 30, 2023

 

 

4,714,388

 

 

 

2.44

 

Exercised during the period

 

 

(252,700)

 

 

2.65

 

Expired during the period

 

 

(24,400)

 

 

2.87

 

Granted

 

 

443,000

 

 

 

3.42

 

Outstanding, September 30, 2024

 

 

4,880,288

 

 

 

2.52

 

Expired during the period

 

 

(2,000)

 

 

3.42

 

Granted

 

 

-

 

 

 

-

 

Outstanding, December 31, 2024

 

 

4,878,288

 

 

 

2.37

 

Exercised during the period

 

 

(18,000)

 

 

3.25

 

Expired during the period

 

 

(17,499)

 

 

3.42

 

Granted

 

 

-

 

 

 

-

 

Outstanding, March 31, 2025

 

 

4,842,789

 

 

 

2.37

 

Exercised during the period

 

 

-

 

 

 

-

 

Expired during the period

 

 

(12,000)

 

 

3.42

 

Granted

 

 

484,000

 

 

 

2.50

 

Outstanding, June 30, 2025

 

 

5,314,789

 

 

 

2.58

 

Schedule of Stock-Based Compensation Costs

Exercise price

 

 

 

Number Outstanding

 

 

Weighted average remaining life (years)

 

 

Number exercisable

 

 

Weighted average exercise price

 

$

2.50

 

 

(Cdn3.4)

 

 

484,000

 

 

 

9.78

 

 

 

133,333

 

 

 

2.50

 

$

3.44

 

 

(Cdn4.68)

 

 

441,000

 

 

 

8.76

 

 

 

205,007

 

 

 

3.44

 

$

3.93

 

 

(Cdn5.35)

 

 

1,002,000

 

 

 

7.78

 

 

 

281,676

 

 

 

3.93

 

$

2.09

 

 

(Cdn2.85)

 

 

298,000

 

 

 

6.97

 

 

 

298,000

 

 

 

2.09

 

$

4.22

 

 

(Cdn5.75)

 

 

20,000

 

 

 

6.41

 

 

 

20,000

 

 

 

4.22

 

$

3.67

 

 

(Cdn5)

 

 

1,494,667

 

 

 

6.20

 

 

 

694,667

 

 

 

3.67

 

$

2.42

 

 

(Cdn3.3)

 

 

270,268

 

 

 

5.20

 

 

 

270,268

 

 

 

2.42

 

$

1.10

 

 

(Cdn1.5)

 

 

1,024,000

 

 

 

4.08

 

 

 

1,024,000

 

 

 

1.10

 

$

1.03

 

 

(Cdn1.4)

 

 

116,566

 

 

 

2.65

 

 

 

116,566

 

 

 

1.03

 

$

4.48

 

 

(Cdn6.1)

 

 

10,667

 

 

 

2.09

 

 

 

10,667

 

 

 

4.48

 

$

7.82

 

 

(Cdn10.65)

 

 

101,121

 

 

 

1.50

 

 

 

101,121

 

 

 

7.82

 

$

2.90

 

 

(Cdn3.95)

 

 

9,600

 

 

 

0.62

 

 

 

9,600

 

 

 

2.90

 

$

2.53

 

 

(Cdn3.45)

 

 

42,900

 

 

 

0.25

 

 

 

42,900

 

 

 

2.53

 

 

 

 

 

 

 

 

5,314,789

 

 

 

 

 

 

 

3,207,805

 

 

 

2.58

 

Schedule of Warrants

 

 

Number Outstanding

 

 

Exercise Price

 

Outstanding, September 30, 2023

 

 

1,711,924

 

 

$2.38

 

Expired

 

 

(291,924)

 

$5.92

 

Outstanding, September 30, 2024

 

 

1,420,000

 

 

$0.63

 

Outstanding, December 31, 2024

 

 

1,420,000

 

 

$0.63

 

Outstanding, March 31, 2025

 

 

1,420,000

 

 

$0.63

 

Outstanding, June 30, 2025

 

 

1,420,000

 

 

$0.63

 

Schedule of Warrant Continuity

 

 

Units

 

 

Fair Value

 

Closing balance (September 30, 2023)

 

 

912,841

 

 

 

1,489

 

Fair value adjustment

 

 

-

 

 

 

(1,334)

Closing balance (September 30, 2024)

 

 

912,841

 

 

 

155

 

Fair value adjustment

 

 

-

 

 

 

(17)

Closing balance (December 31, 2024)

 

 

912,841

 

 

 

138

 

Fair value adjustment

 

 

-

 

 

 

(25)

Closing balance (March 31, 2025)

 

 

912,841

 

 

 

113

 

Fair value adjustment

 

 

-

 

 

 

138

 

Closing balance (June 30, 2025)

 

 

912,841

 

 

 

251